Press "Enter" to skip to content

New patent expiration for Abbvie Inc drug VIEKIRA PAK (COPACKAGED)

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie Inc drug VIEKIRA PAK (COPACKAGED)

Annual Drug Patent Expirations for VIEKIRA+PAK+%28COPACKAGED%29
Annual Drug Patent Expirations for VIEKIRA+PAK+%28COPACKAGED%29

Viekira Pak (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.

Drug patent litigation for VIEKIRA PAK (COPACKAGED).

This drug has five hundred and forty patent family members in fifty-three countries.

The generic ingredient in VIEKIRA PAK (COPACKAGED) is dasabuvir sodium; ombitasvir; paritaprevir; ritonavir. One supplier is listed for this compound. Additional details are available on the dasabuvir sodium; ombitasvir; paritaprevir; ritonavir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie Inc drug VIEKIRA PAK (COPACKAGED)
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!